Compounding pharmacy represents one of healthcare's most volatile sectors, fueled by surging interest in hormone therapy, longevity medicine, and precision dosing. Unlike mass-market pharmaceutical production, the compounding model relies entirely on individual trust. Stonegate Pharmacy, established nearly twenty years ago, built its current footprint through organic demand from providers and patients rather than traditional advertising.

CEO Andy Ruiz noted that the pharmacy’s transition toward a broader national presence is intended to bring quality compounded medications to new communities. According to Zachariah Walden, CEO of Walden Media Group, the agency's primary mandate involves developing a go-to-market strategy that addresses the unique regulatory and provider-relationship requirements of each new state the pharmacy enters. This contract bolsters WMG's existing healthcare portfolio as the agency continues to manage growth for franchise and enterprise-level clients.